CA Patent

CA2064860A1 — Inhalator

Assigned to Boehringer Ingelheim International GmbH · Expires 1991-02-18 · 35y expired

What this patent protects

The invention relates to an inhaler for the inhalation of powdered, more particularly micronised drug preparations from capsules, the housing 10 of the inhaler containing tubular chambers 15 for receiving and holding the capsules, in a revolver magazine with an air inlet at the b…

USPTO Abstract

The invention relates to an inhaler for the inhalation of powdered, more particularly micronised drug preparations from capsules, the housing 10 of the inhaler containing tubular chambers 15 for receiving and holding the capsules, in a revolver magazine with an air inlet at the bottom and an air outlet 25 at the opposite end of the chamber opening into a mouthpiece 11, and a cutting device 19 with two blades 21 which are movable into the interior of the chamber in order to open the capsules near the top and bottom ends thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA2064860A1
Jurisdiction
CA
Classification
—
Expires
1991-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.